drugset / Trial / NCT02005783
Study of Danggui Buxue Decoction in Preventing Neutropenia
RandomizedParallel-groupOpen-labelPrevention
Summary
To evaluate EC/TC (epirubicin and cyclophosphomide or docetaxel and cyclophosphomide) with EC/TC plus DBD (Danggui Buxue Decoction) in adjuvant treatment of breast cancer patients. The aim is to evaluate whether DBD can decrease the incidence of grade 3/4 neutropenia induced by EC/TC regimen during chemotherapy.
Timeline
- Start
- 2013-10
- Primary completion
- 2015-08
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DBD | Unknown | — | Oral |
| Background | Cyclophosphamide | Other / unclassified | 600 mg/m2 | — |
| Background | Docetaxel | Small molecule | 75 mg/m2 | — |
| Background | Epirubicin | Small molecule | 90 mg/m2 | — |